Home > General Cardiology > Angiotensin Neprilysin Inhibition with LV Systolic Dysfunction Heart Failure

Angiotensin Neprilysin Inhibition with LV Systolic Dysfunction Heart Failure

A new combination of valsartan and sacubitril (neprilysin inhibitor) has been shown to reduce from cardiovascular cause of heart failure hospitalization in patients with LV systolic dysfunction heart failure when compared with enalapril 10 mg per day. There was an increased frequency of hypotension but lower rates of renal deterioration and hyperkalemia.

Extracts from the paper are here:

 

paradigme01

paradigme01

 

The paper is availabe here.

The editorial is available here.

Advertisements
  1. No comments yet.
  1. No trackbacks yet.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: